advertisement
Lu F 19
Showing records 1 to 19 | Display all abstracts from Lu F94710 Intraocular asymmetry of visual field defects in primary angle-closure glaucoma, high-tension glaucoma, and normal-tension glaucoma in a Chinese population
Jiang J
Scientific reports 2021; 11: 11674
95280 In vivo non-contact measurement of human iris elasticity by optical coherence elastography
Ye S
Journal of biophotonics 2021; 14: e202100116
94605 A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6)
Olander KW
Journal of Glaucoma 2021; 30: 473-480
95280 In vivo non-contact measurement of human iris elasticity by optical coherence elastography
Zhou Y
Journal of biophotonics 2021; 14: e202100116
94605 A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6)
Sato MA
Journal of Glaucoma 2021; 30: 473-480
94710 Intraocular asymmetry of visual field defects in primary angle-closure glaucoma, high-tension glaucoma, and normal-tension glaucoma in a Chinese population
Ye C; Zhang C
Scientific reports 2021; 11: 11674
94605 A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6)
Abrams MA
Journal of Glaucoma 2021; 30: 473-480
95280 In vivo non-contact measurement of human iris elasticity by optical coherence elastography
Bao C; Bao C
Journal of biophotonics 2021; 14: e202100116
94710 Intraocular asymmetry of visual field defects in primary angle-closure glaucoma, high-tension glaucoma, and normal-tension glaucoma in a Chinese population
Ye W
Scientific reports 2021; 11: 11674
94605 A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6)
Jerkins GW
Journal of Glaucoma 2021; 30: 473-480
95280 In vivo non-contact measurement of human iris elasticity by optical coherence elastography
Chen Y; Lu F
Journal of biophotonics 2021; 14: e202100116
94605 A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6)
Lu F
Journal of Glaucoma 2021; 30: 473-480
94710 Intraocular asymmetry of visual field defects in primary angle-closure glaucoma, high-tension glaucoma, and normal-tension glaucoma in a Chinese population
Wang X
Scientific reports 2021; 11: 11674
95280 In vivo non-contact measurement of human iris elasticity by optical coherence elastography
Zhu D
Journal of biophotonics 2021; 14: e202100116
94710 Intraocular asymmetry of visual field defects in primary angle-closure glaucoma, high-tension glaucoma, and normal-tension glaucoma in a Chinese population
Shang X
Scientific reports 2021; 11: 11674
94605 A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6)
Dinh P; Odani-Kawabata N
Journal of Glaucoma 2021; 30: 473-480
94710 Intraocular asymmetry of visual field defects in primary angle-closure glaucoma, high-tension glaucoma, and normal-tension glaucoma in a Chinese population
Xu X; Zhang H
Scientific reports 2021; 11: 11674
94605 A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6)
Chabi A; Shams NK
Journal of Glaucoma 2021; 30: 473-480
94710 Intraocular asymmetry of visual field defects in primary angle-closure glaucoma, high-tension glaucoma, and normal-tension glaucoma in a Chinese population
Zhang S; Zheng J; Zuo J; Hu J; Congdon N; Lu F; Liang Y
Scientific reports 2021; 11: 11674
